Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Scelsi

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 4, 2022
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisStephan Rosenkranz, Christine Pausch, John G Coghlan, et al.
Vascular Pharmacology|March 1, 2026
2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspectiveGiovanna Manzi, Roberto Badagliacca, Michele D'Alto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Cardiovascular Diagnosis and Therapy|January 24, 2022
Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD RegistryAnn-Sophie Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Giornale Italiano Di Cardiologia (2006)|May 5, 2026
[Substance-related cardiovascular diseases: definition, distinctive features and clinical implications of a novel nosological entity]Francesco Ciccirillo, Maurizio Giuseppe Abrignani, Maria Alfarano, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment'Cristina Chimenti, Attilio Iacovoni, Andrea Montalto, et al.
Giornale Italiano Di Cardiologia (2006)|April 28, 2025
[ANMCO Position paper: Hypertrophic cardiomyopathy: from diagnosis to treatment]Cristina Chimenti, Attilio Iacovoni, Andrea Montalto, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
Vascular Pharmacology|December 1, 2025
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk scoreSilvia Papa, Michele D'Alto, Laura Scelsi, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial HypertensionJoshua Hodgson, Emilia M Swietlik, Richard M Salmon, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 4, 2022
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisStephan Rosenkranz, Christine Pausch, John G Coghlan, et al.
Vascular Pharmacology|March 1, 2026
2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspectiveGiovanna Manzi, Roberto Badagliacca, Michele D'Alto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Cardiovascular Diagnosis and Therapy|January 24, 2022
Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD RegistryAnn-Sophie Kaemmerer, Matthias Gorenflo, Dörte Huscher, et al.
Giornale Italiano Di Cardiologia (2006)|May 5, 2026
[Substance-related cardiovascular diseases: definition, distinctive features and clinical implications of a novel nosological entity]Francesco Ciccirillo, Maurizio Giuseppe Abrignani, Maria Alfarano, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment'Cristina Chimenti, Attilio Iacovoni, Andrea Montalto, et al.
Giornale Italiano Di Cardiologia (2006)|April 28, 2025
[ANMCO Position paper: Hypertrophic cardiomyopathy: from diagnosis to treatment]Cristina Chimenti, Attilio Iacovoni, Andrea Montalto, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
Vascular Pharmacology|December 1, 2025
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk scoreSilvia Papa, Michele D'Alto, Laura Scelsi, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial HypertensionJoshua Hodgson, Emilia M Swietlik, Richard M Salmon, et al.
Pageof 13